We are live on ! Find out more
MGWM

Marks Group Wealth Management Portfolio holdings

AUM $1.04B
1-Year Est. Return 8.96%
This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+8.96%
3 Year Est. Return
+52.46%
5 Year Est. Return
+69.47%
10 Year Est. Return
AUM
$1.02B
AUM Growth
-$32.2M
Cap. Flow
-$22.1M
Cap. Flow %
-2.18%
Top 10 Hldgs %
18.02%
Holding
302
New
9
Increased
80
Reduced
132
Closed
16

Top Sells

Rank Stock Value
1
ALC icon
Alcon
ALC
+$1.15M
2
ACN icon
Accenture
ACN
+$1.02M
3
EIX icon
Edison International
EIX
+$920K
4
FCN icon
FTI Consulting
FCN
+$824K
5
TSM icon
TSMC
TSM
+$778K

Sector Composition

Rank Sector Weight
1 Industrials 24.59%
2 Technology 18.97%
3 Financials 17.51%
4 Healthcare 11.66%
5 Consumer Discretionary 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
76
Intuitive Surgical
ISRG
$122B
$5.8M 0.57%
11,109
-82
-0.7% -$42.7K
CTAS icon
77
Cintas
CTAS
$81.8B
$5.02M 0.49%
27,465
+381
+1% +$80.1K
CVCO icon
78
Cavco Industries
CVCO
$4.36B
$5.01M 0.49%
11,226
+89
+0.8% +$40.9K
JPM icon
79
JPMorgan Chase
JPM
$907B
$4.87M 0.48%
20,329
-295
-1% -$68.7K
BRK.B icon
80
Berkshire Hathaway Class B
BRK.B
$1.06T
$4.86M 0.48%
10,726
+94
+0.9% +$43.4K
TMO icon
81
Thermo Fisher Scientific
TMO
$198B
$4.73M 0.47%
9,091
+271
+3% +$149K
NVR icon
82
NVR
NVR
$17.5B
$4.64M 0.46%
567
+10
+2% +$91.1K
IDXX icon
83
Idexx Laboratories
IDXX
$44.8B
$4.55M 0.45%
11,009
+869
+9% +$381K
EMXC icon
84
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.4B
$4.47M 0.44%
80,613
+2,796
+4% +$164K
EXPD icon
85
Expeditors International
EXPD
$23.9B
$4.28M 0.42%
38,612
+1,016
+3% +$121K
MNST icon
86
Monster Beverage
MNST
$95.4B
$4.1M 0.4%
78,040
+967
+1% +$51.3K
SPY icon
87
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$4.09M 0.4%
6,977
+464
+7% +$273K
IXN icon
88
iShares Global Tech ETF
IXN
$8.65B
$4M 0.39%
47,164
+1,424
+3% +$120K
DCI icon
89
Donaldson
DCI
$10.5B
$3.96M 0.39%
58,792
DELL icon
90
Dell
DELL
$256B
$3.53M 0.35%
30,651
-286
-0.9% -$35.9K
FAST icon
91
Fastenal
FAST
$52.2B
$3.31M 0.33%
92,144
-3,256
-3% -$127K
TDG icon
92
TransDigm Group
TDG
$67.9B
$3.3M 0.33%
2,606
+156
+6% +$206K
XOM icon
93
ExxonMobil
XOM
$611B
$3.2M 0.31%
29,702
-74
-0.2% -$8.66K
VRSK icon
94
Verisk Analytics
VRSK
$26.3B
$3.19M 0.31%
11,573
+151
+1% +$42K
ADSK icon
95
Autodesk
ADSK
$46.1B
$3.15M 0.31%
10,669
+26
+0.2% +$7.68K
IT icon
96
Gartner
IT
$9.39B
$3.14M 0.31%
6,486
+165
+3% +$85.1K
NVDA icon
97
NVIDIA
NVDA
$4.91T
$3.13M 0.31%
23,320
+11
+0% +$1.52K
GOF icon
98
Guggenheim Strategic Opportunities Fund
GOF
$2.27B
$2.99M 0.3%
196,262
AZN icon
99
AstraZeneca
AZN
$262B
$2.95M 0.29%
22,476
+640
+3% +$89.6K
MDT icon
100
Medtronic
MDT
$106B
$2.76M 0.27%
34,612
+349
+1% +$30.2K

Similar funds

Marks Group Wealth Management's Q4 2024 Portfolio in Review

As of Q4 2024, Marks Group Wealth Management held 302 positions worth $1.02B, down 3.1% from $1.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marks Group Wealth Management's Q4 2024 filing shows 9 new, 80 increased, 132 reduced and 16 closed positions. Its largest new stake was Spotify: 1,196 shares worth $535K. The largest sale was Alcon, an estimated $1.15M.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 25% a quarter earlier, followed by Technology and Financials.

  • Marks Group Wealth Management's largest Q4 2024 buy was Spotify: 1,196 shares worth $535K.
  • Marks Group Wealth Management added most to Becton Dickinson in Q4 2024, an estimated $854K increase.
  • Marks Group Wealth Management's biggest Q4 2024 reduction was Alcon, cutting an estimated $1.15M.
  • Marks Group Wealth Management fully exited Rentokil in Q4 2024, selling an estimated $452K.
  • Marks Group Wealth Management's ten largest holdings make up 18% of its $1.02B portfolio in Q4 2024.
  • Marks Group Wealth Management opened 9 new positions and closed 16 in Q4 2024.
  • Marks Group Wealth Management's portfolio value fell 3.1% quarter-over-quarter to $1.02B.

Based on Marks Group Wealth Management's 13F filing for Q4 2024, filed 29 Jan 2025.